title: A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab.
abstract: Tumor necrosis factor-alpha antagonism is an important treatment strategy in patients with rheumatoid arthritis, psoriatic arthritis, vasculitis, and ankylosing spondylitis. Adalimumab is one of the well-known tumor necrosis factor-alpha blocking agents. There are several side effects reported in patients with adalimumab therapy. Cardiac side effects of adalimumab are rare. Only a few cardiac side effects were reported. A 61-year-old man treated with adalimumab for the last 6 months due to psoriatic arthritis presented with typically acute pleuropericarditis. Chest X-ray and echocardiography demonstrated marked pericardial effusion. Patient was successfully evaluated for the etiology of acute pleuro-pericarditis. Every etiology was excluded except the usage of adalimumab. Adalimumab was discontinued, and patient was treated with 1200 mg of ibuprofen daily. Control chest X-ray and echocardiography after three weeks demonstrated complete resolution of both pleural and pericardial effusions. This case clearly demonstrated the acute onset of pericarditis with adalimumab usage. Acute pericarditis and pericardial effusion should be kept in mind in patients with adalimumab treatment.
authors: Department of Cardiology, Medical Park Hospital, Hasim Iscan Cad, Fomara Meydani, No. 1, Osmangazi, 16220 Bursa, Turkey.
authors: Hakan
authors: H
authors: Ozkan
authors: Ahmet Seckin
authors: AS
authors: Cetinkaya
authors: Tekin
authors: T
authors: Yildiz
authors: Tahsin
authors: T
authors: Bozat
references: Clin Nephrol. 2006 Apr;65(4):290-3
references: 16629230
references: Int J Rheum Dis. 2009 Apr;12(1):74-7
references: 20374322
references: Clin Immunol. 2008 Jan;126(1):13-30
references: 17916445
references: Lung. 2010 Dec;188(6):505-10
references: 20827555
references: Case Rep Infect Dis. 2013;2013:796437
references: 23401813
references: Clin Immunol. 2008 Feb;126(2):121-36
references: 17916444